基本信息
views: 288
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I have worked as an epidemiologist and statistician in epidemiological research for 25 years. Most of the time and most recently in Henrik Hjalgrim's group - which covers a lot of ground in terms of diseases, exposures and study designs. I consider myself a consultant on all things to do with data - including presenting it. This work has resulted in 160+ co-athorships and an h-index of 57. I'm first or senior author on 17 papers, e.g. on methodology, infectious mononucleosis, childhood cancer, ovarian cancer, breast cancer, Hodgkin lymphoma and screening of blood products.
My biggest current research interests are:
1) Epstein-Barr virus associated diseases
2) Register-based studies in transfusion medicine
3) Practical methodology for Bayesian and likelihood inference
4) Methodology for stratification and aggregation of follow-up time
I am the creator of state of the art free software (a giant SAS macro) for stratifying and aggregating risk-time and events.
And I have been PhD-assessor at Dept of Biostatistics, Copenhagen University, 2015.
Research Interests
Papers共 225 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Vascular Health and Risk Management (2024): 125-140
Cited0Views0Bibtex
0
0
TRANSFUSIONno. 4 (2024): 647-655
Communications Medicineno. 1 (2024): 1-15
VASCULAR HEALTH AND RISK MANAGEMENT (2024): 125-140
Signe Holst Soegaard, Mie Molgaard Andersen,Klaus Rostgaard,Olafur Birgir Davidsson,Sjurdur Frodi Olsen,Kjeld Schmiegelow,Henrik Hjalgrim
JAMA NETWORK OPENno. 3 (2024): e243115-e243115
BLOOD (2024): 102523-102523
American journal of hematologyno. 8 (2023): 1236-1245
Transfusion (2023): 1710-1718
Load More
Author Statistics
#Papers: 223
#Citation: 7992
H-Index: 52
G-Index: 82
Sociability: 7
Diversity: 4
Activity: 42
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn